BEAM THERAPEUTICS INCBEAM
ASignal's systematic analysis rates BEAM as Bearish.
Reflects the latest available analysis · analyzed Sep 17, 2026
The case on BEAM
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong cash position with $1.15B in total cash
- Low debt-to-equity ratio of 0.23x indicating conservative leverage
- High current and quick ratios (14.57x and 14.25x) suggesting strong liquidity
- RSI at 23.45 indicating potential oversold condition
- Negative price momentum (-0.1599) and declining trend
- MACD below signal line with negative histogram, indicating bearish momentum
- Negative free cash flow (-$241.84M) and operating cash flow (-$359.38M)
- Severe negative operating margin (-25827.14%) and gross margin (-161.91%)
- Revenue growth YoY at -94.20%, indicating sharp decline in top line
- EV/EBITDA of -3.94x and negative profit margins reflect unprofitable operations
See the full verdict on BEAM
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes BEAM
Most investors never get a second opinion, let alone several. ASignal runs BEAM past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.